STOCKS & COMMODITIES magazine. The Traders' Magazine

Technical Analysis of STOCKS & COMMODITIES
The Traders’ Magazine since 1982
has had over 1,226,237 subscribers from 174 different countries.
37,000 Page Traders’ Archive for $89.99


Article Archive For Keyword: Sciences

  • A Look At Gilead Sciences, Inc.

    ARTICLE SYNOPSIS...When Jim Cramer on "CNBC Squawk on the Street" says that he likes a stock, is it worth looking at?

  • Edward Life Sciences: Pumping Into The Stratosphere?

    ARTICLE SYNOPSIS...This stock is probably not on your radar screen yet. Maybe it should be.

  • Gilead Sciences and the Ulcer Index

    ARTICLE SYNOPSIS...One of the worst performing sectors this past year has been the Health Care sector, and of its sub-sectors, Biotechnology was one of the poorest performers. Gilead Sciences (GILD), a component of that sub-sector lost about 21% over the past year, making

  • Gilead Sciences, Inc.

    ARTICLE SYNOPSIS...A share to keep an eye on, but is it due for a correction?

  • Gilead Sciences, Inc.

    ARTICLE SYNOPSIS...Gilead Sciences, Inc. (GILD) President and COO John Milligan sold 100,000 shares for $10.3 million on September 8, 2015. What does that suggest?

  • Gilead Sciences: Upward Momentum Slowing

    ARTICLE SYNOPSIS...Shares of Gilead Sciences, Inc. have been in a long-term bull market for several years, but warnings of a bearish trend reversal are now in place.






S&C Subscription/Renewal




Request Information From Our Sponsors 

DEPARTMENTS: Advertising | Editorial | Circulation | Contact Us | BY PHONE: (206) 938-0570

PTSK — The Professional Traders' Starter Kit
Home — S&C Magazine | Working Money Magazine | Traders.com Advantage | Online Store | Traders’ Resource
Add a Product to Traders’ Resource | Message Boards | Subscribe/Renew | Free Trial Issue | Article Code | Search

Copyright © 1982–2024 Technical Analysis, Inc. All rights reserved. Read our disclaimer & privacy statement.